CN104472569A - Medical sanitizer and preparation method thereof - Google Patents
Medical sanitizer and preparation method thereof Download PDFInfo
- Publication number
- CN104472569A CN104472569A CN201410697155.5A CN201410697155A CN104472569A CN 104472569 A CN104472569 A CN 104472569A CN 201410697155 A CN201410697155 A CN 201410697155A CN 104472569 A CN104472569 A CN 104472569A
- Authority
- CN
- China
- Prior art keywords
- parts
- acid
- ethanol
- hedp
- glycol distearate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention relates to a medical sanitizer and a preparation method thereof, and belongs to the field of sanitizers. The medical sanitizer comprises the following components in parts by weight: 5-10 parts of glycol distearate, 2-7 parts of dodecyl diethanolamide, 2-6 parts of D-glucosaminicacid, 1-5 parts of decyl Polyglucoside, 1-4 parts of tea tree oil, 2-5 parts of almondamidopropylamine oxide, 2-6 parts of an acetic acid, 1-4 parts of an etidronic acid, 2-5 parts of a boric acid, and 20-30 parts of ethanol. The medical sanitizer disclosed by the invention not only has good sterilization performance, but also has a good cleaning effect; the medical sanitizer disclosed by the invention is reasonable in formula, safe and environment-friendly, and has no toxic and side effect on human bodies; and the preparation method disclosed by the invention is simple and practicable, and suitable for wide-range popularization and application.
Description
Technical field
The invention belongs to disinfectant technical field, be specifically related to a kind of medical disinfectant and preparation method thereof.
Background technology
Disinfectant, for killing pathogenic microorganism on communication media, makes it reach innoxious requirement, is eliminated by pathogenic microorganism outside human body, cuts off the route of transmission of infectious disease, reaches the object controlling infectious disease.
Disinfectant can be divided into bactericidal agent, high effect disinfectants, middle effect disinfectants, low effect disinfectants according to its exposure level.Bactericidal agent can kill all microorganisms makes it reach sterilizing requirement, comprises formaldehyde, glutaraldehyde, oxirane, Peracetic acid, hydrogen peroxide, chlorine dioxide, chlorine, copper sulphate, quicklime and ethanol etc.High effect disinfectants can kill all bacterial propagules (comprising mycobacterium), virus, fungi and spore thereof etc., also certain killing effect is had to bacterial spore, reach high level disinfection requirement, comprise chlorine-containing disinfectant, ozone, methyl hydantoin compounds, double-chain quaternary ammonium salt etc.Middle effect disinfectants only can kill the microorganisms such as mycobacterium, fungi, virus and bacterial propagule, reaches sterilization requirement, comprises iodine-containing disinfectant, alcohol disinfectant, disinfectant phenolic etc.Low effect disinfectants only can kill vegetative forms of bacteria and close nma virus, reaches disinfectant requirement, comprises the biguanides disinfectants such as quaternary ammonium disinfectant, Chlorhexidine such as benzalkonium bromide, metal ion class disinfectant and the Chinese herbal disinfectants such as mercury, silver, copper.Disinfectant is also " chemosterilant " by usual people.
But the reasonability of existing medical disinfecting agent prescription is still to be improved, and excitant is comparatively large, although it has good sterilization, its spatter property is poor.
In sum, the deficiency solving prior art existence has become this area technical problem urgently to be resolved hurrily.
Summary of the invention
The present invention, in order to solve the deficiencies in the prior art, provides a kind of medical disinfectant and preparation method thereof, and this sanitizer formulations is reasonable, safety and environmental protection, and has the effect of excellent kill bacteria and stronger cleaning action.
The technical solution used in the present invention is as follows:
Medical disinfectant, comprises the following component according to weight parts: glycol distearate 5-10 part, lauryl diethanolamide 2-7 part, D-Glucosaminic acid 2-6 part, Dodecyl Polyglucosides 1-5 part, tea oil 1-4 part, babassu oil amido propyl amine oxide 2-5 part, acetic acid 2-6 part, HEDP 1-4 part, boric acid 2-5 part, ethanol 20-30 part.
Described medical disinfectant, comprises the following component according to weight parts: glycol distearate 6-9 part, lauryl diethanolamide 3-6 part, D-Glucosaminic acid 3-5 part, Dodecyl Polyglucosides 2-4 part, tea oil 2-3 part, babassu oil amido propyl amine oxide 3-4 part, acetic acid 3-5 part, HEDP 2-3 part, boric acid 3-4 part, ethanol 22-28 part.
Described medical disinfectant, comprises the following component according to weight parts: glycol distearate 7-8 part, lauryl diethanolamide 4-5 part, D-Glucosaminic acid 3-4 part, Dodecyl Polyglucosides 2-3 part, tea oil 2-3 part, babassu oil amido propyl amine oxide 3-4 part, acetic acid 3-4 part, HEDP 2-3 part, boric acid 3-4 part, ethanol 24-26 part.
Described medical disinfectant, comprises the following component according to weight parts: glycol distearate 6 parts, lauryl diethanolamide 3 parts, D-Glucosaminic acid 3 parts, Dodecyl Polyglucosides 2 parts, tea oil 2 parts, babassu oil amido propyl amine oxide 3 parts, acetic acid 3 parts, HEDP 2 parts, boric acid 3 parts, ethanol 22 parts.
Described medical disinfectant, comprises the following component according to weight parts: glycol distearate 9 parts, lauryl diethanolamide 6 parts, D-Glucosaminic acid 5 parts, Dodecyl Polyglucosides 4 parts, tea oil 3 parts, babassu oil amido propyl amine oxide 4 parts, acetic acid 5 parts, HEDP 3 parts, boric acid 4 parts, ethanol 28 parts.
Described medical disinfectant, comprises the following component according to weight parts: glycol distearate 7 parts, lauryl diethanolamide 4 parts, D-Glucosaminic acid 3 parts, Dodecyl Polyglucosides 2 parts, tea oil 2 parts, babassu oil amido propyl amine oxide 3 parts, acetic acid 3 parts, HEDP 2 parts, boric acid 3 parts, ethanol 24 parts.
Described medical disinfectant, comprises the following component according to weight parts: glycol distearate 8 parts, lauryl diethanolamide 5 parts, D-Glucosaminic acid 4 parts, Dodecyl Polyglucosides 3 parts, tea oil 3 parts, babassu oil amido propyl amine oxide 4 parts, acetic acid 4 parts, HEDP 3 parts, boric acid 4 parts, ethanol 26 parts.
The preparation method of described medical disinfectant, comprise the steps: according to weight proportion, by glycol distearate, lauryl diethanolamide, D-Glucosaminic acid, Dodecyl Polyglucosides, tea oil and babassu oil amido propyl amine oxide mixing and stirring, successively acetic acid, HEDP, boric acid and ethanol are being added wherein, be warming up to 50-60 DEG C, stir 30-50min, treat that nature cools, obtain described medical disinfectant.
compared with prior art, its beneficial effect is in the present invention:the first, medical disinfectant of the present invention not only has excellent sterilization ability, also has good cleaning action; The second, medical disinfecting agent prescription of the present invention is reasonable, and safety and environmental protection, to human non-toxic's side effect; 3rd, preparation method of the present invention is simple, is suitable for applying on a large scale.
Embodiment
Below in conjunction with embodiment, set forth the present invention further.
embodiment 1
Medical disinfectant, comprises the following component according to weight parts: glycol distearate 5 parts, lauryl diethanolamide 2 parts, D-Glucosaminic acid 2 parts, Dodecyl Polyglucosides 1 part, tea oil 1 part, babassu oil amido propyl amine oxide 2 parts, acetic acid 2 parts, HEDP 1 part, boric acid 2 parts, ethanol 20 parts.
The preparation method of described medical disinfectant, comprise the steps: according to weight proportion, by glycol distearate, lauryl diethanolamide, D-Glucosaminic acid, Dodecyl Polyglucosides, tea oil and babassu oil amido propyl amine oxide mixing and stirring, successively acetic acid, HEDP, boric acid and ethanol are being added wherein, be warming up to 50 DEG C, stir 50min, treat that nature cools, obtain described medical disinfectant.
embodiment 2
Medical disinfectant, comprises the following component according to weight parts: glycol distearate 10 parts, lauryl diethanolamide 7 parts, D-Glucosaminic acid 6 parts, Dodecyl Polyglucosides 5 parts, tea oil 4 parts, babassu oil amido propyl amine oxide 5 parts, acetic acid 6 parts, HEDP 4 parts, boric acid 5 parts, ethanol 30 parts.
The preparation method of described medical disinfectant, comprise the steps: according to weight proportion, by glycol distearate, lauryl diethanolamide, D-Glucosaminic acid, Dodecyl Polyglucosides, tea oil and babassu oil amido propyl amine oxide mixing and stirring, successively acetic acid, HEDP, boric acid and ethanol are being added wherein, be warming up to 60 DEG C, stir 30min, treat that nature cools, obtain described medical disinfectant.
embodiment 3
Medical disinfectant, comprises the following component according to weight parts: glycol distearate 6 parts, lauryl diethanolamide 3 parts, D-Glucosaminic acid 3 parts, Dodecyl Polyglucosides 2 parts, tea oil 2 parts, babassu oil amido propyl amine oxide 3 parts, acetic acid 3 parts, HEDP 2 parts, boric acid 3 parts, ethanol 22 parts.
The preparation method of described medical disinfectant, comprise the steps: according to weight proportion, by glycol distearate, lauryl diethanolamide, D-Glucosaminic acid, Dodecyl Polyglucosides, tea oil and babassu oil amido propyl amine oxide mixing and stirring, successively acetic acid, HEDP, boric acid and ethanol are being added wherein, be warming up to 55 DEG C, stir 40min, treat that nature cools, obtain described medical disinfectant.
embodiment 4
Medical disinfectant, comprises the following component according to weight parts: glycol distearate 9 parts, lauryl diethanolamide 6 parts, D-Glucosaminic acid 5 parts, Dodecyl Polyglucosides 4 parts, tea oil 3 parts, babassu oil amido propyl amine oxide 4 parts, acetic acid 5 parts, HEDP 3 parts, boric acid 4 parts, ethanol 28 parts.
The preparation method of described medical disinfectant, comprise the steps: according to weight proportion, by glycol distearate, lauryl diethanolamide, D-Glucosaminic acid, Dodecyl Polyglucosides, tea oil and babassu oil amido propyl amine oxide mixing and stirring, successively acetic acid, HEDP, boric acid and ethanol are being added wherein, be warming up to 52 DEG C, stir 35min, treat that nature cools, obtain described medical disinfectant.
embodiment 5
Medical disinfectant, comprises the following component according to weight parts: glycol distearate 7 parts, lauryl diethanolamide 4 parts, D-Glucosaminic acid 3 parts, Dodecyl Polyglucosides 2 parts, tea oil 2 parts, babassu oil amido propyl amine oxide 3 parts, acetic acid 3 parts, HEDP 2 parts, boric acid 3 parts, ethanol 24 parts.
The preparation method of described medical disinfectant, comprise the steps: according to weight proportion, by glycol distearate, lauryl diethanolamide, D-Glucosaminic acid, Dodecyl Polyglucosides, tea oil and babassu oil amido propyl amine oxide mixing and stirring, successively acetic acid, HEDP, boric acid and ethanol are being added wherein, be warming up to 54 DEG C, stir 45min, treat that nature cools, obtain described medical disinfectant.
embodiment 6
Medical disinfectant, comprises the following component according to weight parts: glycol distearate 8 parts, lauryl diethanolamide 5 parts, D-Glucosaminic acid 4 parts, Dodecyl Polyglucosides 3 parts, tea oil 3 parts, babassu oil amido propyl amine oxide 4 parts, acetic acid 4 parts, HEDP 3 parts, boric acid 4 parts, ethanol 26 parts.
The preparation method of described medical disinfectant, comprise the steps: according to weight proportion, by glycol distearate, lauryl diethanolamide, D-Glucosaminic acid, Dodecyl Polyglucosides, tea oil and babassu oil amido propyl amine oxide mixing and stirring, successively acetic acid, HEDP, boric acid and ethanol are being added wherein, be warming up to 56 DEG C, stir 38min, treat that nature cools, obtain described medical disinfectant.
reference examples 1
Medical disinfectant, comprises the following component according to weight parts: glycol distearate 6 parts, lauryl diethanolamide 3 parts, Dodecyl Polyglucosides 2 parts, tea oil 2 parts, babassu oil amido propyl amine oxide 3 parts, acetic acid 3 parts, HEDP 2 parts, boric acid 3 parts, ethanol 22 parts.
The preparation method of described medical disinfectant, comprise the steps: according to weight proportion, by glycol distearate, lauryl diethanolamide, Dodecyl Polyglucosides, tea oil and babassu oil amido propyl amine oxide mixing and stirring, successively acetic acid, HEDP, boric acid and ethanol are being added wherein, be warming up to 55 DEG C, stir 40min, treat that nature cools, obtain described medical disinfectant.
reference examples 2
Medical disinfectant, comprises the following component according to weight parts: glycol distearate 6 parts, lauryl diethanolamide 3 parts, D-Glucosaminic acid 3 parts, tea oil 2 parts, babassu oil amido propyl amine oxide 3 parts, acetic acid 3 parts, HEDP 2 parts, boric acid 3 parts, ethanol 22 parts.
The preparation method of described medical disinfectant, comprise the steps: according to weight proportion, by glycol distearate, lauryl diethanolamide, D-Glucosaminic acid, tea oil and babassu oil amido propyl amine oxide mixing and stirring, successively acetic acid, HEDP, boric acid and ethanol are being added wherein, be warming up to 55 DEG C, stir 40min, treat that nature cools, obtain described medical disinfectant.
performance Detection:
The embodiment of the present invention 1 to 6 gained finished product, reference examples 1 to 2 gained finished product are carried out performance test, and result is as follows:
Table 1 performance test data
| Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | Embodiment 6 | Reference examples 1 | Reference examples 2 | |
| Sterilization rate, % | 100 | 100 | 100 | 100 | 100 | 100 | 24 | 30 |
| Soil removal efficiency, % | 90 | 92 | 95 | 93 | 93 | 94 | 40 | 50 |
As can be seen from the table, the present invention has excellent performance, and wherein the performance of embodiment 3 is best.In addition gained finished product safety and environmental protection of the present invention, to human body and environmental friendliness.
Claims (8)
1. medical disinfectant, it is characterized in that, comprise the following component according to weight parts: glycol distearate 5-10 part, lauryl diethanolamide 2-7 part, D-Glucosaminic acid 2-6 part, Dodecyl Polyglucosides 1-5 part, tea oil 1-4 part, babassu oil amido propyl amine oxide 2-5 part, acetic acid 2-6 part, HEDP 1-4 part, boric acid 2-5 part, ethanol 20-30 part.
2. medical disinfectant according to claim 1, it is characterized in that, comprise the following component according to weight parts: glycol distearate 6-9 part, lauryl diethanolamide 3-6 part, D-Glucosaminic acid 3-5 part, Dodecyl Polyglucosides 2-4 part, tea oil 2-3 part, babassu oil amido propyl amine oxide 3-4 part, acetic acid 3-5 part, HEDP 2-3 part, boric acid 3-4 part, ethanol 22-28 part.
3. medical disinfectant according to claim 1, it is characterized in that, comprise the following component according to weight parts: glycol distearate 7-8 part, lauryl diethanolamide 4-5 part, D-Glucosaminic acid 3-4 part, Dodecyl Polyglucosides 2-3 part, tea oil 2-3 part, babassu oil amido propyl amine oxide 3-4 part, acetic acid 3-4 part, HEDP 2-3 part, boric acid 3-4 part, ethanol 24-26 part.
4. medical disinfectant according to claim 1, it is characterized in that, comprise the following component according to weight parts: glycol distearate 6 parts, lauryl diethanolamide 3 parts, D-Glucosaminic acid 3 parts, Dodecyl Polyglucosides 2 parts, tea oil 2 parts, babassu oil amido propyl amine oxide 3 parts, acetic acid 3 parts, HEDP 2 parts, boric acid 3 parts, ethanol 22 parts.
5. medical disinfectant according to claim 1, it is characterized in that, comprise the following component according to weight parts: glycol distearate 9 parts, lauryl diethanolamide 6 parts, D-Glucosaminic acid 5 parts, Dodecyl Polyglucosides 4 parts, tea oil 3 parts, babassu oil amido propyl amine oxide 4 parts, acetic acid 5 parts, HEDP 3 parts, boric acid 4 parts, ethanol 28 parts.
6. medical disinfectant according to claim 1, it is characterized in that, comprise the following component according to weight parts: glycol distearate 7 parts, lauryl diethanolamide 4 parts, D-Glucosaminic acid 3 parts, Dodecyl Polyglucosides 2 parts, tea oil 2 parts, babassu oil amido propyl amine oxide 3 parts, acetic acid 3 parts, HEDP 2 parts, boric acid 3 parts, ethanol 24 parts.
7. medical disinfectant according to claim 1, it is characterized in that, comprise the following component according to weight parts: glycol distearate 8 parts, lauryl diethanolamide 5 parts, D-Glucosaminic acid 4 parts, Dodecyl Polyglucosides 3 parts, tea oil 3 parts, babassu oil amido propyl amine oxide 4 parts, acetic acid 4 parts, HEDP 3 parts, boric acid 4 parts, ethanol 26 parts.
8. the preparation method of medical disinfectant according to claim 1, it is characterized in that, comprise the steps: according to weight proportion, by glycol distearate, lauryl diethanolamide, D-Glucosaminic acid, Dodecyl Polyglucosides, tea oil and babassu oil amido propyl amine oxide mixing and stirring, successively acetic acid, HEDP, boric acid and ethanol are being added wherein, be warming up to 50-60 DEG C, stir 30-50min, treat that nature cools, obtain described medical disinfectant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410697155.5A CN104472569A (en) | 2014-11-27 | 2014-11-27 | Medical sanitizer and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410697155.5A CN104472569A (en) | 2014-11-27 | 2014-11-27 | Medical sanitizer and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104472569A true CN104472569A (en) | 2015-04-01 |
Family
ID=52747294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410697155.5A Pending CN104472569A (en) | 2014-11-27 | 2014-11-27 | Medical sanitizer and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104472569A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107260788A (en) * | 2017-06-22 | 2017-10-20 | 上海于泽生物科技有限公司 | A kind of medical disinfectant and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103255005A (en) * | 2013-05-28 | 2013-08-21 | 上海艳紫化工科技有限公司 | Rosemary sterilization-deodorization detergent |
-
2014
- 2014-11-27 CN CN201410697155.5A patent/CN104472569A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103255005A (en) * | 2013-05-28 | 2013-08-21 | 上海艳紫化工科技有限公司 | Rosemary sterilization-deodorization detergent |
Non-Patent Citations (2)
| Title |
|---|
| 宋修军: "《临床骨科药物学》", 31 May 2010 * |
| 薛广波: "《现代消毒学》", 31 July 2002 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107260788A (en) * | 2017-06-22 | 2017-10-20 | 上海于泽生物科技有限公司 | A kind of medical disinfectant and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090176887A1 (en) | Biocidal Compositions and Methods | |
| CN102077828A (en) | Compound disinfectant containing quaternary ammonium salt | |
| CN105012161A (en) | Disinfectant wet tissue | |
| CN113331186B (en) | Foam disinfectant and preparation method thereof | |
| KR101913718B1 (en) | Compositions for sterilization and disinfection comprising octenidine and benzalconium chloride | |
| CN105567453A (en) | Antibacterial liquid detergent | |
| CN111280189A (en) | Disinfectant for food industry and preparation method thereof | |
| US9737076B2 (en) | Disinfectant compositions with hydrogen peroxide | |
| US9538760B2 (en) | Disinfectant compositions with hydrogen peroxide | |
| CN104336014A (en) | Composite double-long-chain hyamine disinfectant | |
| CN103445983B (en) | Novel biological sterilizing liquid soap | |
| CN103719142B (en) | A kind of disinfectant and preparation method thereof and application | |
| CN104472569A (en) | Medical sanitizer and preparation method thereof | |
| CN105010390B (en) | A kind of efficient clothes disinfector | |
| CN111109259A (en) | Composite sterilizing disinfectant | |
| CN103283722A (en) | Compound disinfectant for hospital and application thereof | |
| CN104434994A (en) | Mucocutaneous disinfectant | |
| CN102648710B (en) | Compound glutaraldehyde disinfectant for body of dead person | |
| CN114946890A (en) | Biological environment-friendly disinfectant product for efficiently killing new coronavirus and preparation method thereof | |
| CN113481067A (en) | Laundry detergent with anti-bacterial function and preparation method thereof | |
| CN114515255A (en) | Medical and common disinfectant for sterilization and disinfection and disinfectant wet tissue solution | |
| CN105255620A (en) | Leather detergent | |
| CN106172491A (en) | A kind of preparation method of aqueous disinfection sanitizer | |
| CN107260788A (en) | A kind of medical disinfectant and preparation method thereof | |
| CN106852348A (en) | A kind of compound livestock and poultry thimerosal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150401 |
|
| RJ01 | Rejection of invention patent application after publication |